DUBLIN--(BUSINESS WIRE)--Feb. 27, 2014--
plc (NYSE: MNK), a global specialty pharmaceutical and global medical
imaging company, will present at the Barclays Global Healthcare
Conference in Miami, Florida on March 13, 2014. Mark Trudeau, President
and CEO of Mallinckrodt will represent the company in a session
scheduled to begin at 10:45AM EST.
A live audio webcast of the presentation can be accessed at
Mallinckrodt’s Investor Relations website: http://www.mallinckrodt.com/investor_relations
Mallinckrodt is a global specialty pharmaceutical and medical imaging
business that develops, manufactures, markets and distributes specialty
pharmaceutical products and medical imaging agents. The company’s
Specialty Pharmaceuticals segment includes branded and specialty generic
drugs and active pharmaceutical ingredients, and the Global Medical
Imaging segment includes contrast media and nuclear imaging agents.
Mallinckrodt has approximately 5,500 employees worldwide and a
commercial presence in roughly 70 countries. The company’s fiscal 2013
revenue totaled $2.2 billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
John Moten, 314-654-6650
Vice President, Investor
Manager, Media Relations